Bionest Partners and Scisive Consulting Merge
News Jan 29, 2013
Success in today’s competitively evolved medical industry requires insightful strategy informed by operating practicalities. Bionest Partners has combined with Scisive Consulting to create a new model consulting firm intensely responsive to, and highly qualified for, the planning needs of a new generation of medical business leaders and investors. This fusion of two highly-respected medical business consultancies equips us to deal with the new demands of the medical marketplace, and also enables each to augment its intellectual capital and expand its geographic coverage.
Bionest Partners’ new senior management team will be Alain J. Gilbert and Bob J. Easton, as Co-Chair, together with partners Dr. Mary Koto, Catharine Staughton, Olivier Lesueur and Dr. Sean Hu, offering:
• Complementarity of leadership, at once Strategic with Bob J. Easton and Operational with Alain J. Gilbert, to guarantee our clients "Practical Operability" of our recommendations
• Broader sector and deeper functional expertise: drugs/devices/diagnostics (including personalized medicine); research/development/marketing/planning/pricing/corporate development
• Personalized Medicine Strategy, widely recognized consulting expertise
• Geographic reach, with offices in Paris, London, New York, San Diego and affiliates in Munich and Tokyo
New Partnership to Provide Bioanalytical and DMPK ServicesNews
Concept Life Sciences, the integrated drug discovery, development and analytical services company, and Alderley Analytical, bioanalytical Contract Research Organisation (CRO), today announced they have signed a partnership agreement to provide high-value bioanalytical and DMPK study services.
Toothpaste Ingredient Could Help Fight Drug-Resistant MalariaNews
An ingredient commonly found in toothpaste could be employed as an anti-malarial drug against strains of malaria parasite that have grown resistant to one of the currently-used drugs.READ MORE
Small Compound Able to Stave Tumor and Stop its GrowthNews
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital nutrient glutamine.READ MORE